Add to ORKGEstrogen-only menopausal hormone therapy (HT) increases the risk of endometrial cancer, but less is known about the association with other types of HT. Using Cox proportional hazards regression, the authors examined the association of various types of HT with the risk of endometrial cancer among 115,474 postmenopausal women recruited into the European Prospective Investigation into Cancer and Nutrition between 1992 and 2000. After a mean follow-up period of 9 years, 601 incident cases of endometrial cancer were identified. In comparison wit
Most of the data on menopausal hormone therapy (HT) and breast cancer risk available up to the mid-1...
Obesity and menopausal estrogen therapy are established risk factors for endometrial cancer. However...
There is extensive epidemiological evidence that menopausal hormone therapy (MHT) increases breast c...
Estrogen-only menopausal hormone therapy (HT) increases the risk of endometrial cancer, but less is ...
Estrogen-only menopausal hormone therapy (HT) increases the risk of endometrial cancer, but less is ...
Background: Menopausal hormone therapy (MHT) is an appropriate treatment for women with the climacte...
TheWomen’s Health Initiative trial found a modestly increased risk of invasive breast cancer with da...
The association between menopausal hormone therapy (HT) and risk of ovarian cancer was assessed amon...
We assessed whether different oral progestogens in hormone replacement therapy may differentially af...
Menopausal hormone therapy (MHT) is characterized by use of different constituents, regimens and rou...
Menopausal hormone therapy (MHT) is characterized by use of different constituents, regimens and rou...
Endometrial cancer is the most common gynecologic malignancy in the United States, with an estimated...
The authors further analyzed results from the Women’s Health Initiative randomized trials (1993–2004...
Our aim was to determine the risk of endometrial cancer associated with long-term use of combined ho...
Background: Postmenopausal women who use hormone-replacement therapy (HRT) containing oestrogen alon...
Most of the data on menopausal hormone therapy (HT) and breast cancer risk available up to the mid-1...
Obesity and menopausal estrogen therapy are established risk factors for endometrial cancer. However...
There is extensive epidemiological evidence that menopausal hormone therapy (MHT) increases breast c...
Estrogen-only menopausal hormone therapy (HT) increases the risk of endometrial cancer, but less is ...
Estrogen-only menopausal hormone therapy (HT) increases the risk of endometrial cancer, but less is ...
Background: Menopausal hormone therapy (MHT) is an appropriate treatment for women with the climacte...
TheWomen’s Health Initiative trial found a modestly increased risk of invasive breast cancer with da...
The association between menopausal hormone therapy (HT) and risk of ovarian cancer was assessed amon...
We assessed whether different oral progestogens in hormone replacement therapy may differentially af...
Menopausal hormone therapy (MHT) is characterized by use of different constituents, regimens and rou...
Menopausal hormone therapy (MHT) is characterized by use of different constituents, regimens and rou...
Endometrial cancer is the most common gynecologic malignancy in the United States, with an estimated...
The authors further analyzed results from the Women’s Health Initiative randomized trials (1993–2004...
Our aim was to determine the risk of endometrial cancer associated with long-term use of combined ho...
Background: Postmenopausal women who use hormone-replacement therapy (HRT) containing oestrogen alon...
Most of the data on menopausal hormone therapy (HT) and breast cancer risk available up to the mid-1...
Obesity and menopausal estrogen therapy are established risk factors for endometrial cancer. However...
There is extensive epidemiological evidence that menopausal hormone therapy (MHT) increases breast c...